Month: <span>June 2022</span>

Home / 2022 / June
Enzymes linked with immune cell activity could hold key to better understanding inflammation
Post

Enzymes linked with immune cell activity could hold key to better understanding inflammation

by Adrianna MacPherson, University of Alberta Credit: CC0 Public Domain New research shows a group of enzymes may have a critical role in the process of how immune cells are activated and then migrate to certain sites in the body—findings that could improve our understanding of inflammation and potentially lead to new treatments. In a...

Most long-COVID sufferers battle neurological symptoms, including some cognitive issues never seen before
Post

Most long-COVID sufferers battle neurological symptoms, including some cognitive issues never seen before

JUNE 20, 2022 by Jocelyn Solis-Moreira People continue to experience neurological problems six months after recovering from a COVID-19 infection, finds a recent study from the University of California San Diego. In fact, scientists say most coronavirus long-haulers battle brain-related issues. The findings are part of a long-term study tracking the progression of neurological symptoms...

New model helps identify mutations that drive cancer
Post

New model helps identify mutations that drive cancer

Anne Trafton | MIT News Office Publication Date: June 20, 2022 Caption: An MIT-led team has built a new system that rapidly scans the genome of cancer cells, could help researchers find targets for new drugs. Credits: Image: Dylan Burnette and Jennifer Lippincott-Schwartz, National Institutes of Health, edited by MIT News Cancer cells can have...

This May Be the COVID Variant Scientists Are Dreading
Post

This May Be the COVID Variant Scientists Are Dreading

David Axe Published Jun. 20, 2022 3:20AM ET  Photo Illustration by Thomas Levinson/The Daily Beast/Getty COVID-19 cases are increasing again in the United Kingdom, potentially signaling a future surge in infections in the United States and other countries. A pair of new subvariants of the dominant Omicron variant—BA.4 and BA.5—appear to be driving the uptick in cases...

America’s first CRISPR trial is still nearly 100% effective 3 years on
Post

America’s first CRISPR trial is still nearly 100% effective 3 years on

By Rich Haridy June 19, 2022 The new data reports nearly 100 percent success in 75 patients treated with efficacy persisting up to three years beyond the initial treatment Depositphotos Incredible new data presented recently at the European Hematology Association Congress has revealed an experimental CRISPR gene editing therapy is both safe and effective up...

Post

BONE LOSS MEDS MAY LOWER OVARIAN CANCER RISK

Researchers compared medications taken by more than 50,000 women over the age of 50, using de-identified medical records from 2004–2013, to analyze differences in those with ovarian cancer and those without. Women who used nitrogen-based bisphosphonates were found to be less likely to develop ovarian cancer, says Karen Tuesley, a PhD candidate at the University of Queensland...

New screening technology could increase the number of cancer tests done on a solid tumor by 50 times
Post

New screening technology could increase the number of cancer tests done on a solid tumor by 50 times

by  University of Strathclyde, Glasgow Microfluidic tumor-stromal co-culture for CAR-T studies. (A) Image of the OC3D Single microfluidic device used (ScreenIn3D Ltd, U.K.) with schematic showing principle of cell seeding. A single-cell suspension flows through a microchannel and cells sediment into microwell traps below the microchannel level. Scale bar = 10 mm. (B) Brightfield and fluorescence images...